This link will take you to a page that’s not on LinkedIn

Demonstrating its continued and sustained impact on the lives of people in low- and middle-income countries (LMICs) across the world, the Medicines Patent Pool (MPP) today publishes its 2025 annual re...

Monday 18 May Item 13.3 – Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement STATEMENT Delivered by Hillary Mutungi We commend negotiators for their continued efforts to build co...

MPP delivered a statement at the sixth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement, which was conducted in hybrid format on 23–28 March 2026. Statement delivere...

YouTube video by MedicinesPatentPool

Monday, 18 May 2026 – Committee A Agenda item 13.3 – Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement STATEMENT Delivered by Hillary Mutungi We commend negotiators for their co...

The Medicines Patent Pool (MPP) and Roche have signed a voluntary licence agreement to expand access to baloxavir marboxil (Xofluza®), an innovative antiviral treatment for influenza recommended by th...

As the Medicines Patent Pool (MPP) prepares to formally launch its Strategy 2026–2030 in May, we invite you to join a dedicated information session outlining our five-year ambition. During this 90-mi...